TipRanks
Go Ultimate55% OFF

Azitra Inc (AZTR) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Atr12-351Netherton SyndromePhase IRecruitingEvaluation of Topical ATR12-351 in Adults With Netherton SyndromeNov 07, 2023―
Atr-04Papulopustular Rosacea, Epidermal Growth Factorphase1AndPhase2SuspendedStudy to Evaluate the Safety of ATR-04Jan 14, 2021―
Atr04-484, VehicleEgfr Inhibitor-Associated Rashphase1AndPhase2Recruiting――

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Azitra Inc (AZTR) have in its pipeline
Azitra Inc AZTR is currently developing the following drugs: Atr12-351, Atr-04, Atr04-484, Vehicle. These drug candidates are in various stages of clinical development as the company works toward FDA approval.